• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804350-18
Device Problems Difficult to Remove (1528); Difficult to Advance (2920); Device Dislodged or Dislocated (2923)
Patient Problem Unspecified Tissue Injury (4559)
Event Date 04/21/2022
Event Type  Injury  
Event Description
It was reported that the procedure was to treat a mildly tortuous, mildly calcified proximal left anterior descending artery that is 90% stenosed.The lesion was pre-dilated with a 3.0x12mm non-abbott balloon.A 3.5x18mm xience skypoint stent delivery system (sds) was attempted to be advanced; however, it was difficult to advance thru the distal tip of the guide catheter.An additional attempt was made to keep advancing, but was unsuccessful.The sds was removed; however, resistance was noted and the stent became dislodged.A 1.5mm unspecified balloon was used to attempt to move the stent into the guide catheter with the balloon inflated but failed.Additionally, the stent was attempted to be removed into a protective sheath via snare, but was unsuccessful.A cut down was performed at the femoral artery to remove the stent.A non-abbott stent was then used to successfully complete the procedure.There was no adverse patient sequela; however, a clinically significant delay was reported.No additional information was provided.
 
Manufacturer Narrative
The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported difficulties; however, the delay to treatment/ therapy and subsequent treatments appear to be related to the operational context of the procedure.Additionally, the cause of the reported removal of foreign body was due to the dislodged stent in the anatomy.Factors that could contribute to a difficult to advance include, but are not limited to, inner diameter of guide wire lumen, outer diameter of the guide wire, patient¿s anatomical morphology, damage to the guide wire, damage to the catheter, and/or accumulation of procedural contaminants in the guide wire lumen.Factors that could contribute to a dislodged stent include, but not limited to, improper or inadequate crimping at the time of manufacture, forced sheath removal, handling of the stent during preparation, interaction with challenging anatomy, and/or interaction with accessory devices.Factors that could contribute to a difficult to remove include, but are not limited to, damage to the balloon, stent wall apposition, interaction with challenging anatomy, and/or interaction with accessory devices.In this case, it is possible that the stent delivery system (sds) interacted with the mildly calcified, mildly tortuous, and 90% stenosed lesion and/or guide catheter during advancement, resulting in the reported difficult to advance.Further interaction with the challenging anatomy and/or guide catheter during removal, as resistance was noted, possibly resulted in the reported difficult to remove and subsequent dislodged stent; however, this cannot be confirmed.Additionally, the stent was attempted to be removed into a protective sheath via snare but was unsuccessful.A cut down was performed at the femoral artery to remove the stent.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14359555
MDR Text Key291409978
Report Number2024168-2022-05147
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233401
UDI-Public08717648233401
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1804350-18
Device Catalogue Number1804350-18
Device Lot Number110074A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/14/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
-
-